Medtecs International Corporation Limited (9103.TW)

TWD 5.04

(-1.95%)

Total Debt Summary of Medtecs International Corporation Limited

Medtecs International Corporation Limited's latest annual total debt in 2023 was 26.9 Million USD , up 37.6% from previous year.
Medtecs International Corporation Limited's latest quarterly total debt in 2024 Q2 was 24.03 Million USD , up 0.04% from previous quarter.
Medtecs International Corporation Limited reported annual total debt of 19.55 Million USD in 2022, up 15.95% from previous year.
Medtecs International Corporation Limited reported annual total debt of 16.86 Million USD in 2021, down -53.96% from previous year.
Medtecs International Corporation Limited reported quarterly total debt of 26.9 Million USD for 2023 Q4, up 10.39% from previous quarter.
Medtecs International Corporation Limited reported quarterly total debt of 26.9 Million USD for 2023 FY, up 37.6% from previous quarter.

Annual Total Debt Chart of Medtecs International Corporation Limited (2023 - 2009)

Historical Annual Total Debt of Medtecs International Corporation Limited (2023 - 2009)

Year	Total Debt	Total Debt Growth
2023	26.9 Million USD	37.6%
2022	19.55 Million USD	15.95%
2021	16.86 Million USD	-53.96%
2020	36.62 Million USD	-20.55%
2019	46.09 Million USD	12.95%
2018	40.81 Million USD	13.12%
2017	36.07 Million USD	16.92%
2016	30.85 Million USD	0.04%
2015	30.84 Million USD	-10.45%
2014	34.44 Million USD	-17.66%
2013	41.83 Million USD	0.85%
2012	41.47 Million USD	4.78%
2011	39.58 Million USD	-11.2%
2010	44.57 Million USD	22.08%
2009	36.51 Million USD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	24.03 Million USD	0.04%
2023 Q4	26.9 Million USD	10.39%
2023 FY	26.9 Million USD	37.6%
2023 Q2	24.37 Million USD	24.65%
2022 FY	19.55 Million USD	15.95%
2022 Q4	19.55 Million USD	-46.99%
2022 Q2	36.88 Million USD	118.74%
2021 Q4	16.86 Million USD	13.42%
2021 FY	16.86 Million USD	-53.96%
2021 Q2	14.86 Million USD	-59.4%
2020 FY	36.62 Million USD	-20.55%
2020 Q4	36.62 Million USD	-17.7%
2020 Q2	44.5 Million USD	-3.47%
2019 FY	46.09 Million USD	12.95%
2019 Q4	46.09 Million USD	17.44%
2019 Q2	39.25 Million USD	-3.83%
2018 Q2	39.48 Million USD	9.45%
2018 Q4	40.81 Million USD	3.36%
2018 FY	40.81 Million USD	13.12%
2017 Q2	31.97 Million USD	3.62%
2017 Q4	36.07 Million USD	12.84%
2017 FY	36.07 Million USD	16.92%
2016 Q4	30.85 Million USD	-5.43%
2016 FY	30.85 Million USD	0.04%
2016 Q2	32.62 Million USD	5.78%
2015 Q2	35.78 Million USD	3.9%
2015 FY	30.84 Million USD	-10.45%
2015 Q4	30.84 Million USD	-13.82%
2014 FY	34.44 Million USD	-17.66%
2014 Q4	34.44 Million USD	-5.56%
2014 Q2	36.47 Million USD	-12.81%
2013 FY	41.83 Million USD	0.85%
2013 Q4	41.83 Million USD	-0.79%
2013 Q2	42.16 Million USD	1.65%
2012 FY	41.47 Million USD	4.78%
2012 Q4	41.47 Million USD	-3.2%
2012 Q2	42.85 Million USD	8.25%
2011 FY	39.58 Million USD	-11.2%
2011 Q2	42.38 Million USD	-4.93%
2011 Q4	39.58 Million USD	-6.59%
2010 Q2	22.42 Million USD	-38.6%
2010 FY	44.57 Million USD	22.08%
2010 Q4	44.57 Million USD	98.84%
2009 Q2	43.61 Million USD	0.0%
2009 Q4	36.51 Million USD	-16.27%
2009 FY	36.51 Million USD	0.0%

Peer Total Debt Comparison of Medtecs International Corporation Limited

Name	Total Debt	Total Debt Difference
Nang Kuang Pharmaceutical Co., Ltd.	605.96 Million TWD	95.56%
Maxigen Biotech Inc.	50 Thousand TWD	-53710.0%
SciVision Biotech Inc.	347.91 Million TWD	92.267%
Bionime Corporation	2.81 Billion TWD	99.045%
Pegavision Corporation	1.56 Billion TWD	98.28%
Visco Vision Inc.	1.08 Billion TWD	97.517%